Introduction
Filoviruses (viruses of the genera Marburgvirus and Ebolavirus in the family Filoviridae) are enveloped, negative-stranded RNA viruses. These viruses are known to cause severe hemorrhagic fever in humans and/or nonhuman primates. To date, there is one known species in the genus Marburgvirus, consisting of two distinct viruses, Marburg virus (MARV) and Ravn virus. On the other hand, five distinct species are known in the genus Ebolavirus. The Ebola virus (EBOV) representing the species, Zaire ebolavirus, is thought to be the most pathogenic among the five known species in the genus Ebolavirus, with case-fatality rates of up to 90%.
Among MARVs, strain Angola caused the largest outbreak in 2004-05 in Angola, with the highest mortality rate (90%) [1, 2] . A novel bat-derived filovirus, named Lloviu virus, was recently found in Cueva del Lloviu, Asturias, Spain, and tentatively classified into the newly proposed genus Cuevavirus in the family Filoviridae [3, 4] .
The viral envelope glycoprotein (GP) is the only spike protein of filoviruses and thus responsible for virus entry into host cells. Filovirus GP undergoes proteolytic cleavage by host proteases such as furin, resulting in the two subunits, GP1 and GP2, which are linked by a single disulfide bond [5, 6, 7] . GP1 contains a putative receptor-binding region and mucin-like region (MLR) that has a number of potential N-and O-linked glycosylation sites [8, 9] . It is known that the expression of EBOV GP in cultured cells results in loss of cell-cell interaction as 4 well as cell rounding and detachment of cells from the substrate [10, 11, 12] . It was also proposed that the MLR of GP, which spatially occupies a very large region, might abrogate cell adhesion and/or prevent the interaction between lymphocytes and infected cells by forming a steric shield over host proteins such as integrin β1 and major histocompatibility complex class I (MHC I) on the surfaces of GP-expressing cells [13] . We further reported that the shielding effect was not only observed for EBOV GP but also GPs of other ebolaviruses in different species and MARVs, and that the steric shielding efficiency was correlated with the difference in their relative pathogenicities, suggesting that better shielding effects may possibly be related to higher pathogenicities of particular filovirus strains [14] .
In general, apoptotic death of virus-infected cells is an important host defense mechanism to limit viral spread. Apoptosis via the extrinsic pathway is induced by members of the tumor necrosis factor (TNF) family such as Fas ligand (FasL) and TNF-related apoptosis-inducing ligand (TRAIL). FasL, a type II membrane protein, is dominantly expressed on activated T cells and natural killer cells, whereas Fas, a type I membrane protein and a receptor of FasL, is expressed on the surface in diverse cell population [15, 16, 17] . The binding of apoptosis-inducing ligands to their receptors results in signal transduction in cells and the formation of the death-inducing signaling complex followed by the activation of caspases that ultimately induce cell death [18] . Following induction of apoptosis, morphologic features such as cell shrinkage, nuclear fragmentation, and apoptotic body formation are observed [19] .
To counteract the induction of apoptosis, some viruses have evolved multiple mechanisms that interfere with the death signal in infected cells [20] . Although upregulation of TRAIL and Fas molecules associated with EBOV infection of humans and experimentally infected animals has been reported [21, 22, 23, 24, 25] , it was shown that EBOV did not naturally induce apoptosis in infected cells in vitro. However, no suppressive effect on the TRAIL-induced apoptotic signal has been observed in EBOV-infected cells [25] . In this study, we focused on Fas-mediated signaling, which is one of the major extrinsic pathways for the induction of apoptosis, and found that filovirus GPs formed a steric shield on the cell surface and that GP-expressing cells showed resistance to Fas-induced cell death, suggesting that interference with apoptotic signal transduction may serve as an immune evasion mechanism of filoviruses.
Materials and Methods

Plasmids
For expression of EBOV and MARV GPs, cDNAs encoding full-length GPs of strains Mayinga-76 (Zaire) and Angola (Angola), respectively, were used [14] . Coding regions of the Lloviu virus GP were synthesized in pBS II SK vector (FASMAC) based on the nucleotide sequence of the Lloviu GP [26] . After digestion by restriction enzymes, each gene was cloned 6 into the mammalian expression vector pCAGGS.
Transfection
HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM)(Gibco) supplemented with 10% fetal bovine serum at 37°C with 5% CO 2 . The cells were transfected with plasmids using Lipofectamine 2000 (Mirus) according to the manufacturer's directions. Six hours posttransfection, the culture medium was changed to fresh DMEM supplemented with 10% fetal bovine serum. The cells were collected and washed once with FACS buffer (0.5% FCS and 0.05% sodium azide in PBS), and used for flow cytometric analyses.
Monoclonal antibodies to GPs
Mouse monoclonal antibodies (MAbs) were generated according to a standard procedure reported previously [27, 28] . Zaire GP-specific MAb ZGP746/16.2 (IgG2a), which recognizes amino acid positions 391-410 (TPVYKLDISEATQVEQHHRR) in GP1 [29] , MARV GP-specific MAb MGP14-22 (IgG1), which recognizes amino acid positions 445-465 (FPFLDGLINAPIDFDPVPNTK) in GP2, Lloviu GP-specific MAb LGP14-2 (IgG1), and a vesicular stomatitis virus (VSV) G protein-specific MAb (VSV-G(N)1-9) [28] were purified from mouse ascites using protein A agarose columns (Bio-Rad). Purified ZGP746/16.2, MGP14-22, and LGP14-2 were labeled with Alexa Fluor 488 using an Alexa Fluor 488 Protein Labeling Kit (Invitrogen) for the analysis of shielding effects against Fas (CD95). 
Induction of apoptosis and flow cytometry
Results and discussion
In general, it is believed that a death signal through Fas-FasL interaction on the cell surface is involved in the elimination of virus-infected cells, providing an important defense mechanism against viral infections. It has been demonstrated that filovirus GPs expressed on the cell surface form a steric shield over host proteins and disrupt their interaction with extracellular matrices and immune cells [13, 14, 30] . Thus, we first investigated whether filovirus GPs showed the steric shielding effect against cell surface Fas molecules. HeLa cells were transiently transfected with plasmids expressing Zaire, Angola, or Lloviu GPs and analyzed by flow cytometry with probing antibodies to Fas (Fig. 1) . The steric shielding effect was expected to be observed as decreased detection of the Fas molecule on the cell surface due to the sterically hindered antibody access to the relevant host proteins [13, 30] . We found that a prominent shielding effect for the cell surface Fas molecule was commonly observed on Zaire, Angola, and Lloviu GP-expressing cells (Fig. 1A) . Overall intracellular protein expression levels of Fas were not affected by the expression of these GPs (Fig. 1B) . These results suggested that Fas molecules on GP-expressing cells might be masked by the steric shielding effect. This striking shielding effect is likely due to the relatively small molecular size of Fas (approximately 45kDa) and its localization to lipid rafts together with GP [31, 32] .
To investigate whether GP-mediated steric shielding functionally blocks subsequent apoptotic signaling through Fas-FasL interaction, HeLa cells transfected with GP-expressing plasmids or the vector alone were treated with a Fas agonistic MAb (CH-11) or control MAb (APH159-1-3).
After 3-hour incubation with the MAbs, cells were stained with cell-permeable FLICA and PI to observe caspase induction and cell viability, respectively (Fig. 2) . In control (vector-transfected) cells, 75.1% of cells treated with APH159-1-3 were viable, but only 6.0% of the CH-11-treated cells were viable. Instead, the numbers of late and early apoptotic CH-11-treated cells were remarkably elevated (from 9.9 to 50.4% and from 9.49 to 36.4%, respectively), indicating that Upon incubation with CH-11, viabilities of VSV G-expressing and vector-transfected cells were drastically decreased at 6 and 12 hours, and more than 80% of the cells died during the incubation period. In contrast, more than 60% of the cells expressing filovirus GPs survived even after 12-hour incubation (Fig. 3A) . Cell rounding and detachment, most likely due to the disrupted function of adhesion molecules (e.g., integrins) by GP-mediated steric shielding, were observed in filovirus GP-expressing cells but not in VSV G-transfected or vector-transfected cells (Fig. 3B left panels) . Consistent with the reduced viability of VSV G-and vector-transfected cells, intensive cell death characterized by progressive cell shrinkage through apoptosis was observed in these cells (Fig. 3B right panels) . In contrast, such morphological changes were only slightly observed in GP-expressing cells (i.e., rounded cells) and apoptotic death was exclusively observed in GP-untransfected cells in the same well (Fig. 3B right panels) .
These results indicated that GP-expressing cells were more resistant to cell death induced by Fas-mediated apoptosis than VSV G-or vector-transfected cells.
In this study, we found a reduction in apoptotic signals and higher viability in filovirus GP-expressing cells, suggesting that the steric shielding effect against the Fas molecule might protect filovirus GP-expressing cells from the Fas-mediated apoptotic signal. It is noteworthy that the GP of Lloviu virus, which has not been biologically characterized since no infectious virus has been isolated, also had the potential to suppress Fas-mediated apoptosis, like other filoviruses that cause lethal diseases in humans and nonhuman primates. Moreover, it was confirmed that integrin β1 and MHC I were also masked by the Lloviu virus GP (unpublished data). These observations may provide useful information concerning the pathogenic potential of Lloviu virus. This study suggests that the ability to interfere with functions of host cell surface proteins is likely a common property among the GPs of all filoviruses thus far known.
On the other hand, it was shown previously that the expression levels of EBOV GP were tightly 12 controlled in infected cells, with cytotoxic effects occurring late in infection [33, 34] , and that moderate levels of GP expression might not affect the detection of MHC I and integrin β1 on the cell surface [34] . Thus, we cannot exclude the possibility that GP-mediated steric shielding of the Fas molecule may only be observed when GP is expressed with high density on the cell surface.
Although further investigations using infectious filoviruses are needed to clarify the importance of the steric shielding effect in the pathogenesis in infected animals, this study suggests that GP-mediated steric shielding may play important roles in immune evasion from host responses initiated by various signaling factors, including Fas-mediated apoptosis.
Interestingly, selective apoptosis induced by a dsRNA-dependent caspase recruiter strongly inhibited virus replication, suggesting that apoptosis might be capable of playing an important role in overcoming filovirus infection [25] . Thus, modulation of the signaling machinery including the Fas/FasL interaction may therefore be a useful strategy for the development of antiviral therapeutics. 
